Episode Details

Back to Episodes
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership

Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership

Published 1 month, 1 week ago
Description
Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and Somnivera in a day of new licensing deals, and Corxel's Bo Liang calls GLP-1's leap to bariatric-surgery-level efficacy the biggest surprise in obesity medicine.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us